Liquid Biopsy and Peripheral Immune Status in Cancer Therapy Response

Dear Colleagues,

The shift to personalized oncology has already enabled longer remission and overall survival periods for many cancer patients. The primary tumor is not always accessible or adequate for performing all available biomarker analyses for patient sub-classification. Moreover, due to the rapid development of novel therapeutic interventions, the need for accurate biomarkers should be prioritized. Additionally, cancer development and therapeutic response are complex, multifunctional processes. Therefore, it is starting to become clear that combinatorial biomarkers may offer more accurate diagnostic, prognostic, and predictive results.

This Special Issue on Liquid Biopsy and Peripheral Immune Status in Cancer Therapy Response will focus on the value of novel, easily accessible biomarkers in the response to all types of tumor therapy. We welcome submissions exploring the value of liquid biomarkers such as CTCs, exosomes, ctDNA, and blood immune cell populations.

Dr. Galatea Kallergi
Dr. Anastasia Xagara
Dr. Constantin N. Baxevanis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Onco is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.